AIM vs REGN: Which Stock is Better?
Side-by-side comparison of Aim Immunotech Inc and Regeneron Pharmaceuticals Inc in 2026
AIM
Aim Immunotech Inc
$0.69
REGN
Regeneron Pharmaceuticals Inc
$787.50
Key Metrics Comparison
| Metric | AIM | REGN | Winner |
|---|---|---|---|
| Market Cap | $2.79M | $81.05B | REGN |
| P/E Ratio | N/A | 18.48 | REGN |
| EPS (TTM) | $N/A | $41.48 | REGN |
| Revenue Growth | -0.3% | 0.0% | REGN |
| Gross Margin | 15.2% | 44.6% | REGN |
Analyze AIM
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AIM or REGN a better investment?
Comparing AIM and REGN: Aim Immunotech Inc has a market cap of $2.79M while Regeneron Pharmaceuticals Inc has $81.05B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AIM and REGN?
AIM (Aim Immunotech Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AIM or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: AIM or REGN?
REGN has higher revenue growth at 0.0% vs -0.3% for AIM.
Which company is more profitable: AIM or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 15.2% for AIM.
Which is the larger company: AIM or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $81.05B compared to $2.79M for AIM.
Should I buy AIM or REGN in 2026?
Both AIM and REGN have investment merit. AIM trades at $0.69 while REGN trades at $787.50. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AIM and REGN stock?
Key differences: Market Cap ($2.79M vs $81.05B), P/E Ratio (N/A vs 18.5x), Revenue Growth (-0.3% vs 0.0%), Gross Margin (15.2% vs 44.6%).